SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-057762
Filing Date
2020-05-07
Accepted
2020-05-07 08:01:19
Documents
66
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014589d1_10q.htm 10-Q 642735
2 EXHIBIT 31.1 tm2014589d1_ex31-1.htm EX-31.1 9970
3 EXHIBIT 31.2 tm2014589d1_ex31-2.htm EX-31.2 9871
4 EXHIBIT 32.1 tm2014589d1_ex32-1.htm EX-32.1 3680
5 EXHIBIT 32.2 tm2014589d1_ex32-2.htm EX-32.2 3813
  Complete submission text file 0001104659-20-057762.txt   4691313

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lpcn-20200331.xml EX-101.INS 1196046
7 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20200331.xsd EX-101.SCH 37468
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20200331_cal.xml EX-101.CAL 36472
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20200331_def.xml EX-101.DEF 128704
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20200331_lab.xml EX-101.LAB 302612
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20200331_pre.xml EX-101.PRE 280275
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 20854641
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences